Atlas Trials

Abion Inc

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Abion Inc

RecordFirmDate
To Evaluate the Efficacy, Safety, Tolerability and Pharmacokinetic Profile of ABN401 in Patients With Advanced Solid Tumors Harboring c-MET Dysregulation (NCT05541822)Abion Inc2023-01-17
To Evaluate the Safety, Pharmacokinetic and the Effect of Food After Administration of ABN401 in Healthy Adult Volunteers (NCT05248074)Abion Inc2022-01-04
To Evaluate the Safety, Pharmacokinetics, Pharmacodynamics, and Antitumor Activity of ABN401 in Patients With Advanced Solid Tumors and Non-Small Cell Lung Cancer Harboring c-MET Dysregulation (NCT04052971)Abion Inc2019-08-01

Track Abion Inc automatically

Every clearance here is in the API, with alerts when new ones post.